Answers are grounded in this paper and cite their sources.
Objective and design: The aim of the present study is to review literature associated with the nutritional aspect of the treatment of non‐alcoholic steatohepatitis (NASH). Subjects and setting: The studies reviewed used small numbers of subjects and the majority of the studies were retrospective reviews and case series, not randomised controlled trials. The duration of the studies ranged from seven weeks to two years. Main outcome measures: Almost all of the studies demonstrate improvement in liver function tests, with weight loss combined with exercise beneficially reversing fatty liver. Omega‐3 fatty acid supplementation suggests positive effects in triglycerides level reduction by its role in suppression of sterol regulatory element binding protein‐1, whereas vitamin E supplementation reduces serum transaminase. Nutritional treatment in NASH is directed at its risk factors. Some studies give useful information regarding the importance of the nutritional aspects of treatment of the NASH patient, and almost all of the studies provide positive results although in some regimens the results are inconsistent. Conclusion: Well‐designed trials (in terms of numbers of subjects, with valid outcome measures) are needed to determine the efficacy of each strategy.
No takes yet. Share an insight, caveat, or question.
Yunianingtias et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: